Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£3m Investment for Durham Stem Cell Research

Published: Monday, June 23, 2008
Last Updated: Wednesday, June 25, 2008
Bookmark and Share
STEM cell scientists take a step closer to developing pioneering new therapies with the opening of a £3m trio of laboratories at Durham University.

STEM cell scientists take a step closer to developing pioneering new therapies with the opening of a £3m trio of laboratories at Durham University.

The laboratories will be used for investigations into the therapeutic potential of ‘adult’ stem cells for medical issues such as wound healing and heart disease.

Durham University is a key partner in the North East England Stem Cell Institute (NESCI)*, and employs more than 50 stem cell researchers, including 12 senior academics.

The new laboratories, based on the University’s Science Site on South Road, Durham, have been funded by One North East and the Government’s Science Research Investment Fund.

Durham stem cell scientists are currently working on projects which include using stem cells to generate artificial blood vessels for use in heart transplantation and identifying how stem cells age to obtain knowledge which could be used in drug development.

They are also working with Teesside company, Avecia, to develop stem cell technology for use in wound healing, which will include burns treatment for the skin.

The new facilities opened on Friday June 20, by Sir Ian Wilmut, director of the MRC Centre for Regenerative Medicine at Edinburgh University and co-creator of Dolly the cloned sheep and Margaret Fay, chairman of the regional development agency, One North East, which is also a NESCI partner.

Scientists from outside Durham will also be able to use the facilities to advance their work in adult stem cells.

Professor Chris Hutchison, co-director of NESCI at Durham, said: “These facilities position Durham at the forefront of research in adult stem cells but most importantly will ensure we can take our work to the clinic and to the market within a much shorter timescale than was possible before.”

Stem cells are a special type of cell that has the ability to renew other cells in the body. Adult stem cells are found throughout the body and perform the everyday renewal of existing cells. They are more properly known as ‘somatic’ stem cells and they are present as soon as a baby is born.

The challenge facing stem cell scientists is to find out how these stem cells work naturally in the body, how they may be made to work better, and, potentially, how they may be re-programmed to work in new ways.

Margaret Fay said: “The North East England Stem Cell Institute has a real opportunity to make an invaluable contribution to the region’s economy, its future success and quality of life issues over the coming years.

“Durham University, as a key partner in NESCI, is playing a major part in the North East region, cementing its credentials as a centre of excellence in the field of Healthcare and Health Sciences.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New discovery Could Stimulate Plant Growth and Increase Crop Yields
Researchers at Durham University have discovered a natural mechanism in plants that could stimulate their growth even under stress and potentially lead to better crop yields.
Wednesday, January 15, 2014
Matrix Protein Key to Fighting Viruses
A new approach could help scientists intercept one of the viruses that cause respiratory disease and a third of common colds, according to new research from Durham University.
Monday, May 18, 2009
Matrix Protein Key to Fighting Viruses
Durham University researchers are developing methods that show how proteins interact with cell membranes when a virus strikes.
Thursday, April 30, 2009
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!